INTRODUCTION

Insulin glulisine (brand name Apidra) is a short-acting form of insulin analogue that is used for the treatment of hyperglycemia caused by Type 1 and Type 2 diabetes mellitus.

This plasmid is designed for expressing Insulin glulisine in E.coli expression system.

PRODUCT INFORMATION

Item No.: PPBD-99
Shipping: Lyophilized plasmid, or liquid plasmid, or plasmids on filter paper
Storage: -20 °C or 4°C according to instruction
Plasmid Backbone: Expression plasmid, flexible options, custom available
Quality Control: Sequencing validation

DRUG INFORMATION

Generic Name: Insulin glulisine
Brand Name(s): Apidra
Classification: Insulins
Amino Acid Sequence: Identical to DB01309

PROTOCOL FOR PLASMID RECOVERY FROM FILTER PAPER

REFERENCE

[1] Arnolds S, Rave K, Hövelmann U, Fischer A, Sert-Langeron C, Heise T. Insulin glulisine has a faster onset of action compared with insulin aspart in healthy volunteers. Exp Clin Endocrinol Diabetes. 2010 Oct;118(9):662-4.

[2] Becker RH. Insulin glulisine complementing basal insulins: a review of structure and activity. Diabetes Technol Ther. 2007 Feb;9(1):109-21.

Contact Us